Obesity and Reduced Mobility Obesity can slow circulation and increase pressure within the veins, making clot formation more likely over time
muciniphila supplementation induced variations in immune cell composition (Katiraei et al., 2020), and enhanced peritoneal leukocyte functions, including chemotactic activity, phagocytic efficacy, natural killer activity, and lymphoproliferative capacity (Cerro et al., 2022)
Exenatide, a DPP-4resistant exendin-4 GLP-1 receptor agonist, exhibits the glucoregulatory actions of GLP-1 and reduces body weight in patients with T2DM
A powerful molecule that protects cells from damage, supports detoxification, and boosts immunity
From weighing 117 kg in March 2025, when she started her GLP-1 journey with Ozempic, Dhond is at 95 kg today